Persistent difficulties in nephrology impede the best possible care and results for patients. Kidney illnesses are sometimes diagnosed at late stages, making treatment and management more difficult. Over the past few decades, the primary issue facing the discipline of nephrology has been patients' ignorance of nephrological disorders and symptoms. Even though diabetes and hypertension are becoming more commonplace globally, many people are still unaware of the risks they pose to kidney health.
Professionals in nephrology face additional challenges in meeting patients' psychosocial requirements in addition to their medical demands, as remaining up to date with new developments in technology and therapies necessitates a comprehensive approach. To overcome these challenges and improve kidney health outcomes while offering patients around the world the best care possible, cooperative efforts are required. In order to promote long-lasting improvements in kidney health outcomes, Dr. Indradip Maity emphasizes early intervention, individualized patient care, and open communication. He is a distinguished nephrologist with over a decade of expertise in the medical domain.
Dr. Indradip Maity pursued an MBBS from Manipal University's Kasturba Medical College in Mangalore. After this, he earned his MD in Internal Medicine from Kolkata Medical College and received his DM in Nephrology from All India Institute of Medical Sciences in New Delhi. Dr. Indradip started working as a consultant nephrologist, after completing his intensive training in nephrology, at the Apollo Hospital in Kolkata.
“I was exposed to a wide range of renal disorders during my time at AIIMS Delhi and this has helped me gain valuable insights and expertise in managing a variety of patients. This includes handling various types of kidney transplants, such as cadaveric and incompatible transplants. I am also part of several prestigious boards including the Indian Society of Nephrology, the European Renal Association, and the International Society of Nephrology. All these experiences help me to improve patient care by implementing new guidelines and protocols for renal diseases,” adds Dr. Indradip.
Comprehensive Approach to Care
Dr. Indradip advocates counseling renal disease patients thoroughly to make sure they understand the nature of the disease. Patients need to be aware that kidney disease often progresses to chronic kidney disease (CKD) and is largely irreversible. He stresses that although drugs can impede the progression of CKD, they cannot reverse the damage that has already been done. Therefore, the patient should focus on managing and controlling the conditions instead of expecting a complete reversal of the disease. In his counseling, Dr. Indradip emphasizes the value of awareness and following certain safety measures.
“As an example, medicines, especially nonsteroidal anti-inflammatory drugs (NSAIDs), as well as other medications that include toxins and heavy metals, should be avoided by kidney patients since they can worsen kidney damage. I evaluate patients initially, discuss the underlying causes of their renal failure, and work with them to create a detailed management plan,” informs Dr. Indradip.
The Way Ahead
With regard to nephrology, there are still a lot of exciting innovations in the works. For instance, Artificial Kidney Project are presently underway in the United States. There are numerous issues that renal patients may encounter that this new gadget could potentially solve. Continuous Renal Replacement Therapy (CRRT), which has been increasingly popular over the past five to six years, is another breakthrough. Nowadays, CRRT is widely available, and when started at the appropriate time, it improves outcomes for patients with acute renal damage.
I aim to empower patients & drive sustainable advancements in nephrology by prioritizing early intervention & personalized care
The field of nephrology, especially glomerular diseases, has seen advancements in the last decade. Dr. Indradip points out that drugs such as rituximab have shown promising results and are being used extensively for several ailments. Newer medications such as Dapagliflozin and Empagliflozin, which are SGLT- 2 inhibitors, have revolutionized the way diabetic kidney disease is managed. There has been an emergence of new compounds that target the molecular pathway and mechanisms unique to kidney diseases. Many studies for targeted therapies are being conducted. Dr. Indradip is hopeful that in the next three to five years, advances in new medication may offer a high likelihood of reversibility, even for chronic diseases such as CKD.
“I have seen a lot of progress in the field of nephrology over the years. There has also been a rise in the prevalence of kidney disease, but this has led to advancements in treatment options as well. The public's knowledge of kidney transplants has grown. Interestingly, cadaveric transplants have grown, particularly in the southern region of the nation where active initiatives and increased public awareness have led to a greater volume of transplants. The rise in transplants over the last five years is encouraging for the field of nephrology. There is room for advancement, and I am excited to see what the future holds,” concludes Dr. Indradip.
Dr. Indradip Maity, Consultant Nephrologist, Apollo Multispeciality Hospitals
Dr. Indradip Maity completed his MBBS from Kasturba Medical College, MD in Internal Medicine from Calcutta Medical College, and DM in Nephrology from AIIMS, New Delhi. Currently a Consultant at Apollo Hospital, Kolkata, he focuses on patient education and stays abreast of advancements in nephrology, aiming to improve patient outcomes.
.jpg "Technology in Cancer Care: A story of evolving paradigms")
.jpg "Bringing Shop Floor to Manufacturer's palm: Smart Factory Solutions for tomorrow")
